ARS Pharmaceuticals, Inc. (SPRY): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$0
Year ended 2023-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $0 | n/a | 2025-03-20, From 2023-01-01 |